Rapport Therapeutics, Inc. (RAPP)

NASDAQ: RAPP · Real-Time Price · USD

27.84

-0.83 (-2.90%)

At close: Mar 13, 2026, 4:00 PM EDT

27.91

+0.07 (0.25%)

After-hours: Mar 13, 2026, 7:05 PM EDT

Rapport Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023
Period Ending	Mar '26 Mar 13, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Market Cap	1,331	1,449	649	-
Market Cap Growth	238.71%	123.35%	-	-
Enterprise Value	851.5	967.61	344.39	0
Last Close Price	27.84	30.34	17.74	-
PE Ratio	-	-10.61	-4.69	-
PB Ratio	2.74	2.99	2.12	-
P/TBV Ratio	2.24	2.44	1.21	-
P/FCF Ratio	-	-16.45	-9.65	-
P/OCF Ratio	-	-16.57	-10.01	-
EV/EBITDA Ratio	-	-7.80	-4.19	-
EV/EBIT Ratio	-	-7.73	-4.15	-
EV/FCF Ratio	-	-10.98	-5.12	-
Debt / Equity Ratio	0.02	0.02	0.00	0.01
Debt / EBITDA Ratio	-0.09	-0.09	-0.02	-0.06
Debt / FCF Ratio	-0.13	-0.13	-0.02	-0.07
Net Debt / Equity Ratio	-0.99	-0.99	-0.99	5.67
Net Debt / EBITDA Ratio	3.86	3.86	3.70	4.03
Net Debt / FCF Ratio	5.44	5.44	4.52	5.04
Quick Ratio	25.75	25.75	34.82	16.75
Current Ratio	26.17	26.17	35.34	17.14
Return on Equity (ROE)	-28.22%	-28.22%	-35.09%	-24.68%
Return on Assets (ROA)	-30.24%	-30.24%	-35.32%	-23.28%
Return on Invested Capital (ROIC)	-3464.87%	-3464.87%	-11575.61%	19249.68%
Return on Capital Employed (ROCE)	-31.29%	-31.29%	-36.69%	-24.68%
Earnings Yield	-8.38%	-9.43%	-21.31%	-
FCF Yield	-6.62%	-6.08%	-10.36%	-
Buyback Yield / Dilution	-18.68%	-18.68%	-24.30%	-

Updated Mar 10, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q